Retractable Technologies (Retractable Technologies) Cash-to-Debt : 30.75 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Retractable Technologies's cash to debt ratio for the quarter that ended in Dec. 2023 was 30.75.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Retractable Technologies could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for Retractable Technologies's Cash-to-Debt or its related term are showing as below:

RVP' s Cash-to-Debt Range Over the Past 10 Years
Min: 4.12 Med: 5.69 Max: 30.75
Current: 30.75

During the past 13 years, Retractable Technologies's highest Cash to Debt Ratio was 30.75. The lowest was 4.12. And the median was 5.69.

RVP's Cash-to-Debt is ranked better than
82.13% of 862 companies
in the Medical Devices & Instruments industry
Industry Median: 2.03 vs RVP: 30.75

Retractable Technologies Cash-to-Debt Historical Data

The historical data trend for Retractable Technologies's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Retractable Technologies Cash-to-Debt Chart

Retractable Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

5.19

6.86

20.18

27.15

30.75

Retractable Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															27.15	27.10	26.13	27.91	30.75

Competitive Comparison of Retractable Technologies's Cash-to-Debt

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Retractable Technologies's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Cash-to-Debt falls into.

Retractable Technologies Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Retractable Technologies's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	47.289	/	(0.304	+	1.234)
	=	30.75

Retractable Technologies's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	47.289	/	(0.304	+	1.234)
	=	30.75

Retractable Technologies (AMEX:RVP) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Retractable Technologies Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Retractable Technologies (Retractable Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

511 Lobo Lane, Little Elm, TX, USA, 75068-5295

Website

https://www.retractable.com

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.

Executives

Thomas J Shaw	director, 10 percent owner, officer: President and CEO	511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard	10 percent owner	156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr	director	816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley	director	1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman	director, officer: Vice President of Sales	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii	director, officer: Chief Financial Officer	511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack	director	1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut	director	1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno	10 percent owner	777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August	10 percent owner	340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner	director, officer: Exec. VP, Eng & Prod.	511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza	director	P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu	director	511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King	director	9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios	officer: Vice President/General Counsel	511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines

From GuruFocus

Retractable Technologies Inc (RVP) CEO Thomas J Shaw buys 200,000 Shares

By gurufocus • 03-16-2009

Is Retractable Technologies (RVP) Modestly Undervalued? A Comprehensive Analysis

By GuruFocus Research • 08-22-2023